Form 4 for MGNX MACROGENICS INC
Accepted 2022-10-21 00:00:00 ET · period of report 2022-10-19 · accession 0000899243-22-033943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-21 | 2022-10-19+ | MGNX | BB BIOTECH AG | 10% | P - Purchase | $3.89 | +454.4K | 7.44M | +7% | +$1.77M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-20 | P | A | 285,977 | $4.00 | 7,729,963 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-19 | P | A | 168,422 | $3.70 | 7,443,986 | D | — | — |